Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Amgen
(NQ:
AMGN
)
342.22
-9.10 (-2.59%)
Official Closing Price
Updated: 4:15 PM EST, Jan 28, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,347,792
Open
349.00
Bid (Size)
340.50 (200)
Ask (Size)
343.00 (40)
Prev. Close
351.32
Today's Range
340.00 - 351.95
52wk Range
261.43 - 353.25
Shares Outstanding
538,500,000
Dividend Yield
2.78%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Missed Out on Eli Lilly? This GLP-1 Stock Could Be a Bargain Buy.
↗
January 28, 2026
Amgen may not have an approved GLP-1 treatment just yet, but that could change in the future.
Via
The Motley Fool
The $100 Billion Milestone: Johnson & Johnson Pivots from 'Steady' 2025 to Growth-Focused 2026
January 27, 2026
NEW BRUNSWICK, N.J. — Johnson & Johnson (NYSE: JNJ) has officially closed the chapter on a year many analysts described as "transitional," reporting full-year 2025 earnings that met expectations while...
Via
MarketMinute
Topics
Earnings
Economy
Government
Performance
YTD
+4.5%
+4.5%
1 Month
+3.8%
+3.8%
3 Month
+17.3%
+17.3%
6 Month
+13.6%
+13.6%
1 Year
+22.1%
+22.1%
More News
Read More
The $6 Billion Disconnect: Why Revolution Medicines (RVMD) Plunged 20% After Merck Talks Collapsed
January 26, 2026
Via
Finterra
Topics
Economy
Initial Public Offering
AMGEN INC (NASDAQ:AMGN) Shows High Technical and Setup Ratings for Potential Breakout
↗
January 21, 2026
Via
Chartmill
Q3 Rundown: Amgen (NASDAQ:AMGN) Vs Other Therapeutics Stocks
January 25, 2026
Via
StockStory
Topics
Artificial Intelligence
Johnson & Johnson 2026 Outlook: Chasing the $100 Billion Milestone Amidst Legal and Patent Hurdles
January 23, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Bankruptcy
Economy
Stability Meets Scale: Why Johnson & Johnson is Poised for a Breakout 2026
January 23, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Bankruptcy
Economy
The Trillion-Dollar Heavyweight: Eli Lilly Surge Signals Unrivaled Dominance in the GLP-1 Era
January 22, 2026
Via
MarketMinute
Topics
Economy
Resilience in the Face of the Patent Cliff: Johnson & Johnson Forecasts Landmark 2026 Growth
January 22, 2026
Via
MarketMinute
Topics
Earnings
Economy
Intellectual Property
The 50.9 Mirage: Is the Manufacturing Expansion a True Recovery or a Tariff-Induced Sugar High?
January 20, 2026
Via
MarketMinute
Topics
Economy
Supply Chain
World Trade
The High-Stakes Balancing Act: Johnson & Johnson Braces for Q4 Earnings Amid Patent Cliffs and MedTech Expansion
January 20, 2026
Via
MarketMinute
Topics
Bankruptcy
Earnings
Economy
Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All
↗
January 19, 2026
Via
MarketBeat
Topics
ETFs
2 Dividend Stocks to Buy and Hold For 10 Years
↗
January 19, 2026
Via
The Motley Fool
Topics
Intellectual Property
The Trillion-Dollar Pharmacopeia: Eli Lilly’s (LLY) Dominance in the Age of Incretins
January 19, 2026
Via
Finterra
Topics
Economy
Q3 Therapeutics Earnings: Halozyme Therapeutics (NASDAQ:HALO) Earns Top Marks
January 18, 2026
Via
StockStory
Topics
Artificial Intelligence
The Execution Engine: How Merck is Dominating the 2026 Pharma Landscape
January 15, 2026
Via
MarketMinute
Topics
Economy
Intellectual Property
The $5.1 Trillion Wave: Why 2026 is Set to Become the Biggest Year for Global M&A
January 16, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Amgen at the Crossroads: MariTide, Market Volatility, and the Quest for Obesity Dominance
January 13, 2026
Via
PredictStreet
Topics
Economy
Intellectual Property
1 Healthcare Stock to Keep an Eye On and 2 We Ignore
January 12, 2026
Via
StockStory
Topics
Stocks
The Convergence of Silicon and Science: Eli Lilly and Nvidia Unveil $1 Billion AI Co-Innovation Lab at JPM26
January 12, 2026
Via
MarketMinute
Topics
Artificial Intelligence
The Trillion-Dollar Pharmacist: A 2026 Deep Dive into Eli Lilly (LLY)
January 09, 2026
Via
PredictStreet
Topics
Earnings
Economy
Intellectual Property
J&J Cuts Deal With Trump’s White House To Slash Drug Prices And Dodge Tariffs
↗
January 08, 2026
Via
Stocktwits
Topics
Government
The $20 Billion Question: Revolution Medicines Surges as Big Pharma Circles the Pan-RAS Leader
January 08, 2026
Via
MarketMinute
Topics
Intellectual Property
Can These Dividend Stocks Beat the Market Again in 2026?
↗
January 08, 2026
Via
The Motley Fool
The 2026 Pharma M&A Outlook: Obesity, HIV, and the Biotech Renaissance
January 07, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Frequently Asked Questions
Is Amgen publicly traded?
Yes, Amgen is publicly traded.
What exchange does Amgen trade on?
Amgen trades on the Nasdaq Stock Market
What is the ticker symbol for Amgen?
The ticker symbol for Amgen is AMGN on the Nasdaq Stock Market
What is the current price of Amgen?
The current price of Amgen is 342.22
When was Amgen last traded?
The last trade of Amgen was at 01/28/26 04:15 PM ET
What is the market capitalization of Amgen?
The market capitalization of Amgen is 184.29B
How many shares of Amgen are outstanding?
Amgen has 184B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.